MaxCyte, Inc. (MXCT) Balance Sheet
As of 2026-06-30 (10-Q), MaxCyte, Inc. (MXCT) reported total assets of $184.7M, total liabilities of $25.9M and shareholders' equity of $158.8M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $15.0M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MXCTMaxCyte, Inc.Follow MXCT — free
—
Price chart with a free account
- Market cap
- 144.5M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 47.8 | 11.1 | 46.5 | 27.9 | 20.1 | 15.0 | |
| Short-term investments | 207.3 | 216.3 | 121.8 | 126.6 | 83.0 | 90.6 | |
| Receivables | 6.9 | 11.2 | 5.8 | 4.7 | 3.5 | 3.9 | |
| Inventory | 5.2 | 8.6 | 12.2 | 8.9 | 7.5 | 7.8 | |
| Current assets | 270.4 | 252.3 | 190.2 | 171.7 | 118.4 | 121.3 | |
| Total assets | 284.1 | 286.7 | 268.3 | 239.5 | 202.5 | 184.7 | |
| Current liabilities | 15.6 | 15.4 | 17.9 | 15.8 | 14.3 | 9.9 | |
| Total liabilities | 21.2 | 32.7 | 36.1 | 33.2 | 31.0 | 25.9 | |
| Shareholders' equity | 262.9 | 254.0 | 232.2 | 206.3 | 171.5 | 158.8 |
USD millions · SEC XBRL
MaxCyte, Inc. — questions
- How much cash does MaxCyte, Inc. have?
- $15.0M in cash and cash equivalents as of 2026-06-30.
- What are MaxCyte, Inc.'s total assets?
- $184.7M as of 2026-06-30.
- What is MaxCyte, Inc.'s shareholders' equity?
- $158.8M as of 2026-06-30.
Every figure on this page comes from MaxCyte, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.